子類別 專利 [0/52] 期刊論文 [160/160] 會議論文/會議摘要 [23/37] 鄰近社群 伍素瑩 [53/66] 其他 [58/60] 夏克山 [77/157] 岳嶽 [29/32] 張仲明 [7/9] 張俊彥 [19/20] 張竣評 [21/38] 徐祖安 [170/229] 李秀珠 [76/106] 李靜琪 [24/25] 林書玉 [21/22] 洪明秀 [32/41] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/73] 童俊維 [24/24] 紀雅惠 [21/25] 翁紹華 [23/25] 莊宏 [1/1] 葉修華 [25/26] 葉燈光 [135/154] 蔣維棠 [43/81] 謝興邦 [178/242] 趙宇生(2002-2013) [120/242] 郭靜娟 [51/57] 鄒倫 [28/63] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] 社群統計 近3年內發表的文件:18(7.23%) 含全文筆數:183(73.49%) 文件下載次數統計 下載大於0次:183(100.00%) 下載大於100次:177(96.72%) 檔案下載總次數:100564(1.77%) 最後更新時間: 2025-03-02 05:05 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Natural fucoidans inhibit coronavir... Integrating ultrabright polymer dot... Heterocyclic compounds and use ther... Heterocyclic compounds and use ther... 헤테로사이클릭 화합물과 이의 용도 Composto de fórmula (i) e composiçã... Heterocyclic compounds and use ther... 雜環化合物及其用途 杂环化合物及其用途 雜環化合物及其用途

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目151-175 / 249. (共10頁) << < 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2013-01-23	In vivo imaging of brain infarct with the novel fluorescent probe psvue 794 in a rat middle cerebral artery occlusion-reperfusion model	Molecular Imaging. 2013 Jan 23;12(1):8-16.
2013-01	Effects of pH on molecular mechanisms of chitosan–integrin interactions and resulting tight-junction disruptions	Biomaterials. 2013 Jan;34(3):784-793.
2012-11	BPR1J271, a novel FLT3 inhibitor for treating acute myeloid leukemia	European Journal of Cancer. 2012 Nov;48(Suppl. 6):53-54.
2012-09	Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan	Biomaterials. 2012 Sep;33(26):6254-6263.
2012-09	Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors	European Journal of Medicinal Chemistry. 2012 Sep;55:32-38.
2012-09	Putative tumor metastasis-associated genes in human gastric cancer	International Journal of Oncology. 2012 Sep;41(3):1068-1084.
2012-09	HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy	Clinical Cancer Research. 2012 Sep;18(17):4691-4701.
2012-06-07	3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry Letters. 2012 Jun 7;22(14):4654-4659.
2012-06	Involvement of transcriptional regulator Ndt80 in stress responses of Candida albicans	Mycoses. 2012 Jun;55(Suppl. S4):131-132.
2012-04	Securin enhances the anti-cancer effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in human colorectal cancer cells	PLoS ONE. 2012 Apr;7(4):Article number e36006.
2012-03	R432 is a key residue for the multiple functions of Ndt80p in Candida albicans	Cellular and Molecular Life Sciences. 2012 Mar;69(6):1011-1023.
2012-02	Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents	Investigational New Drugs. 2012 Feb;30(1):164-175.
2012-02	Discovery of novel stem cell mobilizers that target the CXCR4 receptor	ChemMedChem. 2012 Feb;7(2):209-212.
2012-01	BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML	British Journal of Cancer. 2012 Jan;106(3):475-481.
2011-11	Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins	Biomaterials. 2011 Nov;32(33):8712-8721.
2011-10	Antiproliferative effects of N-heterocyclic indolyl glyoxylamide derivatives on human lung cancer cells	Anticancer Research. 2011 Oct;31(10):3407-3415.
2011-09-27	Formulations of indol-3-yl-2-oxoacetamide compounds	US8026271/2011-09-27
2011-09	Effects of dipeptidyl peptidase 4 inhibition with MK-0431 on syngeneic mouse islet transplantation	Diabetologia. 2011 Sep;54(Suppl. 1):S181.
2011-07	Immune response and pathophysiological features of Klebsiella pneumoniae liver abscesses in an animal model	Laboratory Investigation. 2011 Jul;91(7):1029-1039.
2011-07	Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry. 2011 Jul;19(14):4173-4182 .
2011-05	Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4	Journal of Agricultural and Food Chemistry. 2011 May;59(9):4644-4648.
2011-05	Study of glioblastoma multiforme metastatic and invasive mechanism by polycistronic imaging probe in tumor implanted animal model	Journal of Nuclear Medicine. 2011 May;52(Suppl. 1):Meeting Abstract 1709.
2011-03-27	Design and synthesis of potent Aurora kinase inhibitors	Abstracts of Papers - American Chemical Society. 2011 Mar 27;241:258-MEDI.
2011-01-13	Discovery of novel N -Beta- d -Xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes	Journal of Medicinal Chemistry. 2011 Jan 13;54(1):166-178.
2011-01	BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities	Cancer Science. 2011 Jan;102(1):182-191.

顯示項目151-175 / 249. (共10頁) << < 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目